Mild Hyperhomocystinemia In Children And Young Adults Were Placed On Dialysis: A Single Center Study
Journal of Pediatric Nephrology,
Vol. 3 No. 4 (2015),
26 Mehr 2015
,
Page 155-164
https://doi.org/10.22037/jpn.v3i4.9639
Abstract
Introduction: Hyperhomocysteinemia is common in end stage renal diseases. We aimed to determine the prevalence of hyperhomocysteinemia in dialysis cases and define independent risk factors of the development of hyperhomocysteinemia.
Materials and Methods: The total plasma homocysteine values were measured in 46 dialysis patients including 20[43.4 %] girls and 26[56.6 %] boys aged 1.6-25 [19.9±6.5] years based on two different reference values for children [age dependent] and adults [cut off point of 15 µmol/L].
Results: Using the reference values for children, 26 cases [56.2 %] had hyperhomocysteinemia including 41.6% of CAPD and 2/3 of hemodialysis patients with no significant difference based on age, gender, duration and modality of dialysis, and dosage of folate supplement [p>0.05 for all]. Using a cut-off point of 15 µmol/L, hyperhomocysteinemia was reported in 30.4% of the patients including 11 hemodialysis and one CAPD [P=0.022], 10 out of 19 girls [52.6%%] and 4 out of 26 boys [15.4%] [p=0.063], but logistic regression analysis did not show any significant differences in the incidence rate of hyperhomocysteinemia according to the modality of dialysis and gender [P=0.998 and 0.137 respectively].
Conclusions: We found mild hyperhomocysteinemia as a common finding in dialysis patients; also, the prevalence of hyperhomocysteinemia was comparable in children and young adults. However, we noted that hemodialysis patients and females were more prone to more intense elevations of plasma homocysteine levels. We found that neither gender nor modality of dialysis played a role as risk factors for development of hyperhomocysteinemia in children and young adults.
Keywords: Hyperhomocysteinemia; Child; Hemodialysis; Peritoneal dialysis; Adults.How to Cite
References
Schwammenthal Y, Tanne D. Hemocysteine , B-vitamin supplementation, and stroke prevention: from observational to interventional trials. Lancet 2004; 3[8]:493-5.
Wang X1, Qin X, Demirtas H, Li J, Mao G, Huo Y, et al . Efficacy of folic acid supplementation in stroke prevention: a meta-analysis.Lancet. 2007; 369[9576]:1876-82.
Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.JAMA. 2006; 296[22]:2720-6.
Sarvari GR, Naseri M, Esmaeeli M, Azarfar A. Serum folate and vitamin b12 levels in hemodialysis patients: is there any correlation with plasma homocysteine levels? J ped. nephrology .2014;2[4]:140-146.
Ntaios G, Savopoulos C, Grekas D, Hatzitolios A. The controversial role of B-vitamins in cardiovascular risk: An update. Arch Cardiovasc Dis. 2009; 102[12]:847-54.
Grekas D, Economou H, Makedou A. Association between hyperhomocysteinemia and ultrasonography therosclerotic indices of carotid arteries in chronic hemodialysis patients. Nephron Clin Pract 2005; 101:c180—6.
Gruberg L, Rai P, Mintz GS, Canos D, Pinnow E, Satler LF, et al.Impact of renal function on coronary plaque morphology and morphometry in patients with chronic renal insufficiency as determined by intravascular ultrasound volumetric analysis. Am J Cardiol 2005; 96: 892–896.
Papoutsakis C, Yiannakouris N, Manios Y,Papaconstantinou E, Magkos F, Schulpis KH, et al. Plasma homocysteine concentrations in greek children are influenced by an interaction between the methylenetetrahydrofolate reductase C677T genotype and folate status. J Nutr 2005; 135: 383–388.
González-Gross M, Benser J, Breidenassel C, Albers U, Huybrechts I, Valtueña J, et al .Gender and age influence blood folate, vitamin B12,vitamin B6, and homocysteine levels in European adolescents: the Helena Study. Nutrition Research 2012; 32:817 – 826.
Alodaib AN, Carpenter K, Wiley V, Wotton T, Christodoulou J, Wilcken B.Homocysteine measurement in dried blood spot for neonatal detection of homocystinurias. JIMD Rep2012; 5: 1-6.
Vilaseca MA, Moyano D, Ferrer I, Artuch R. Total homocysteine in pediatric patients. Clin Chem. 1997; 43:690–692.
De Laet C,Wautrecht J. C, Brasseur D, Dramaix M, Boeynaems J. M, Decuyper J, et al. Plasma hemocysteine concentration in a Belgian school-age population. Am. J. Clin. Nutr. 1999; 69: 968–972.
Pawlak K, Mysliwiec M, Pawlak D.Hyperhomocystinemia and the presence of cardiovascular disease are associated with kynurenic acid levels and carotid atherosclerosis in patients undergoing continuous ambulatory peritoneal dialysis. Thrombosis Research. 2012; 129: 704–709.
Lentz SR, Haynes WG. Homocysteine: Is it a clinically important cardiovascular risk factor? Cleveland Clinic Journal of Medicine 2004; 71[9]:730-735.
Alfathan G, Aro A, Gay KF.Plasma homocysteine and cardiovascular mortality. Lancet .1997; 349 [9043]: 397.
Gollbahar J,Bararpour H.normal range of total plasma homocysteine concentration in Southern Iran. Iran J Med sci. 2003;28[3];139-142.
Must A, Jacques PF, Rogers G, Rosenberg IH, Selhub J. Serum Total Ho mocysteine Concentrations in Children and Adolescents: Results from the Third National Health and Nutrition Examination Survey [NHANES III].J Nutr.2003; 133:2643-2649.
Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004 50:3–32.
Clase CM, Ki V, Holden RM. Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review.Semin Dial. 2013; 26[5]:546-67.
Rees L, Shaw V. Nutrition in children with CRF and on dialysis. Pediatr Nephrol 2007; 22:1689–1702.
Shaw V, Lawson M [eds]. In Clinical Paediatric Dietetics, 3rd edn, Blackwell Science, London, England, 2006,632 pages.
Akanji AO, Thalib L, Al-Isa AN . Folate, vitamin B₁₂ and total homocysteine levels in Arab adolescent subjects: reference ranges and potential determinants.Nutr Metab Cardiovasc Dis. 2012; 22[10]:900-6.
Kharlamova UV, Il'icheva OE.Effect of homocysteine on left ventricular structural and functional parameters in patients on programmed hemodialysis. Ter Arkh .2013; 85[3]:90-3
Farid FA, Faheem MS, Heshmat NM, Shaheen KY, Saad SS. Study of the homocysteine status in children with chronic renal failure.Am J Nephrol. 2004; 24[3]:289-95.
Koulouridis E, Tzilianos M, Katsarou A, Costimba I, Klonou E, Panagiotaki E. Homocysteine and C-reactive protein levels in hemodialysis patients. Int Urol Nephrol. 2001; 33[2]:207-15.
Schröder CH , de Boer AW, Giesen AM, Monnens LAH, Blom Treatment of hyperhomocystinemia in children on dialysis by folic acid. Pediatr Nephrol .1999; 13:583–585.
Lilien M, Duran M, Van Hoeck K, Poll-The BT , Schroder C.Hyperhomocysteinaemia in children with chronic renal failure. Nephrol Dial Transplant .1999; 14: 366–368.
Feinstein S, Sela BA, Drukker A, Becker-Cohen R, Raveh D, Gavendo S, Frishberg Y. Hyperhomo -cysteinemia in children on renal replacement therapy. Pediatr Nephrol. 2002;17[7]:515-9.
Ertek S, Torun AN, Ates K. The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients.Int Urol Nephrol. 2010 42[1]:211-8.
Taskapan H, Senel S, Ulutas O, Taskapan MC, Aksoy Y, Kosar F, et al . Platelet activity and serum homocysteine levels in patients with end-stage renal failure with regard to dialysis modality. Ren 2006; 28 [4]:303-8.
Borazan A, Aydemir S, Sert M, Yilmaz A. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels. Mediators Inflamm. 2004; 13[5-6]:361-4.
Nair AP, Nemirovsky D, Kim M, Geer EB, Farkouh ME, Winston J, et al.Elevated homocysteine levels in patients with end-stage renal disease. Mt Sinai J Med 2005; 72[6]:365-73.
Bostom AG, Lathrop L. Hyperhomocystinemiain end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997; 52[1]:10-20..
Kharlamova UV, Il'icheva OE.Effect of homocysteine on left ventricular structural and functional parameters in patients on programmed hemodialysis. Ter Arkh. 2013; 85[3]:90-3.
Cetin O, Bekpinar S, Unlucerci Y, Turkmen A, Bayram C, Ulutin T.Hyperhomocystinemia in chronic renal failure patients: relation to tissue factor an De Vecchi d platelet aggregation. Clin Nephrol. 2006; 65[2]:97-102.
- Abstract Viewed: 290 times
- PDF Downloaded: 158 times